Patents for C07K 19 - Hybrid peptides (29,428) |
---|
03/13/2013 | CN1606618B Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease |
03/13/2013 | CN102971340A Antibodies with enhanced or suppressed effector function |
03/13/2013 | CN102965387A Trx-hPTN fusion protein and production method thereof |
03/13/2013 | CN102965325A msCT-CTx fusion protein transgenic engineering strain |
03/13/2013 | CN102964453A Osteogenic growth peptide-calcitonin gene related peptide fusion protein and encoding gene thereof |
03/13/2013 | CN102964452A msCT-rhLeptin fusion protein for treating osteoporosis and obesity and nucleic acid encoding fusion protein |
03/13/2013 | CN102964451A msCT-CTx fusion protein for treating osteoporosis and reliving pain and nucleic acid encoding fusion protein |
03/13/2013 | CN102964450A OGP-AcAP2 (Osteogenic Growth Peptide) fusion protein for treating osteoporosis and thrombus and nucleic acid for coding fusion protein |
03/13/2013 | CN102961761A Quantum dot targeting probe for colorectal cancer tumor tissue identification and preparation method thereof |
03/13/2013 | CN102321179B Hepatitis C virus recombination protein and gene sequence |
03/13/2013 | CN102234657B Fusion protein for resisting chicken coccidiosis, preparation and application thereof |
03/13/2013 | CN101962413B Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof |
03/13/2013 | CN101597335B Recombined protein specially combined with fiber protein and application thereof |
03/13/2013 | CN101492507B Complex of Fab fragment of C2H7 and CD20 antigen epitope polypeptide |
03/13/2013 | CN101302256B Novel recombinant fusion molecule and antineoplastic treatment function thereof |
03/12/2013 | US8394771 Multimeric proteins and methods of making and using same |
03/12/2013 | CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
03/12/2013 | CA2407910C Antibodies that immunospecifically bind to blys |
03/07/2013 | WO2013033658A1 Self-assembled nanostructures |
03/07/2013 | WO2013033363A1 Mycobacterium tuberculosis porins and toxins and related methods |
03/07/2013 | WO2013033104A1 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR DECTIN-1 AND TOLL-LIKE RECEPTOR 2 (TLR2) |
03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
03/07/2013 | WO2013031882A1 Vaccine preparation for cancer treatment |
03/07/2013 | WO2013029205A1 Cleavable protein of interferon fused with human serum albumin and encoding gene and use thereof |
03/07/2013 | WO2013009690A3 Leukemia stem cell targeting ligands and methods of use |
03/07/2013 | US20130060010 Design and development of masked therapeutic antibodies to limit off-target effects |
03/07/2013 | US20130059793 Egf receptor mimicking peptides |
03/07/2013 | US20130059785 Gene and Polypeptide Sequences |
03/07/2013 | US20130059780 Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
03/07/2013 | US20130059752 Compositions and methods for the treatment of immune related diseases |
03/07/2013 | US20130058994 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
03/07/2013 | US20130058962 Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein |
03/07/2013 | US20130058908 High affinity ny-eso t cell receptors |
03/07/2013 | US20130058873 P97 fragments with transfer activity |
03/07/2013 | CA2847527A1 Bmp peptides & methods of use |
03/07/2013 | CA2847442A1 Mycobacterium tuberculosis porins and toxins and related methods |
03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
03/07/2013 | CA2847332A1 Vaccine preparation for cancer treatment |
03/07/2013 | CA2847173A1 Viral clearance methods |
03/07/2013 | CA2846852A1 Fap-activated proteasome inhibitors for treating solid tumors |
03/06/2013 | EP2563912A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
03/06/2013 | EP2563911A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
03/06/2013 | EP2563817A2 Fluorescent fusion polypeptides and methods of use |
03/06/2013 | EP2563808A1 Peptide conjugates of glp-1 receptor agonists and gastrin and their use |
03/06/2013 | CN102952836A Recombinant human long-acting interleukin-1 receptor antagonist fusion protein purification method |
03/06/2013 | CN102952193A Antigenic epitope displaying method based on single domain antibody |
03/06/2013 | CN102952192A Fusion protein containing Exendin-4 and application thereof |
03/06/2013 | CN102250255B Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof |
03/06/2013 | CN102241778B PPA-linker-Thanatin fusion protein and preparation method thereof |
03/06/2013 | CN101511868B Exendin fusion proteins |
03/05/2013 | US8389690 Antibodies to JTT-1 protein and cells secreting such antibodies |
02/28/2013 | WO2013028996A1 Self-assembled bead-based multiplexed assay for antigen-specific antibodies |
02/28/2013 | WO2013027796A1 IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME |
02/28/2013 | WO2013027217A1 Zymoxins and methods of using the same |
02/28/2013 | WO2013026334A1 Cell dna synthesis prevention and cell proliferation inhibition polypeptide and use thereof |
02/28/2013 | WO2013026105A1 Pest-controlling agents isolated from spider venom and uses thereof |
02/28/2013 | WO2012159006A3 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof |
02/28/2013 | US20130053544 Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds |
02/28/2013 | US20130053322 Hsa-related compositions and methods of use |
02/28/2013 | US20130053271 Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies |
02/28/2013 | US20130052229 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
02/28/2013 | US20130052217 Tumor vaccination involving a humoral immune response against self-proteins |
02/28/2013 | US20130052216 Targeted heterologous antigen presentation on calicivirus virus-like particles |
02/28/2013 | US20130052213 Novel immunomodulatory peptide |
02/28/2013 | US20130052193 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR TOLL-LIKE RECEPTOR 2 (TLR2) |
02/28/2013 | US20130052192 Activatable Constructs |
02/28/2013 | US20130052182 Method of reducing biofilms |
02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
02/28/2013 | CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof |
02/27/2013 | EP2560684A1 Fibronectin type iii domain-based multimeric scaffolds |
02/27/2013 | CN102947341A Engineered opsonin for pathogen detection and treatment |
02/27/2013 | CN102947324A Peptide domains that bind small molecules of industrial significance |
02/27/2013 | CN102942618A Telomeric protein polypeptide fragment with tumor cell killing activity and application thereof |
02/27/2013 | CN102942616A Peptide capable of binding to immunoglobulin |
02/27/2013 | CN102940880A Growth factor complex |
02/26/2013 | CA2674885C Anti-ige vaccines |
02/26/2013 | CA2674837C Anti-ige vaccines |
02/26/2013 | CA2633345C A method of affinity separation and ligands for use therein |
02/26/2013 | CA2524399C Optimized fc variants and methods for their generation |
02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
02/26/2013 | CA2380302C Production of proteins by autoproteolytic cleavage |
02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
02/21/2013 | WO2013025846A2 Transferrin-tumstatin fusion protein and methods for producing and using the same |
02/21/2013 | WO2013025079A1 Method for preparing active form of tnfr-fc fusion protein |
02/21/2013 | WO2013025052A2 Bioactive carbon nanotube composite functionalized with β-sheet polypeptide block copolymer, and preparation method thereof |
02/21/2013 | US20130045922 Pro-angiogenic fragments of prominin-1 and uses thereof |
02/21/2013 | US20130045917 Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof |
02/21/2013 | US20130045205 Methods and Compositions Related to Glycoprotein-Immunoglobulin Fusions |
02/21/2013 | CA2849015A1 Transferrin-tumstatin fusion protein and methods for producing and using the same |
02/21/2013 | CA2845536A1 Anti-b7-h4 antibodies and their uses |
02/20/2013 | EP2558503A1 Compositions and methods for brain delivery of analgesic peptides |
02/20/2013 | CN102939303A Tetravalent cd47-antibody constant region fusion protein for use in therapy |
02/20/2013 | CN102936288A Erythropoietin mimetic peptide fusion protein and mutant |
02/20/2013 | CN102936281A RTRAIL(recombinant TNF(tumor necrosis factor) related apoptosis-inducing ligand) mutant and monomethyl auristatin E(MMAE) conjugate thereof |
02/20/2013 | CN102936278A Epitope polypeptide of dengue virus type 2 NS3 protein and application thereof |
02/20/2013 | CN102936277A Human blood vessel endothelial growth factor antigen epitope and epitope vaccine thereof |
02/19/2013 | CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
02/19/2013 | CA2485120C Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |